Jarret Fass is the founder and managing partner of Pierpoint Capital, a family office–backed platform that invests in and builds healthcare technology companies in the U.S. and Israel. 

As a passionate business builder, Jarret cofounded, capitalized, and is an active board member of three clinical-stage medical technology companies: Hemodynamx (aortic stenosis), Nephronyx (heart failure), and Emanate Biomedical (oral diseases) of which he is serving as CEO. He also currently sits on the board of LeanTaas (AI-powered health system operations) and CoreFlow (aeromechanical manufacturing automation). 

Previously, Jarret led the firm’s investment in and was responsible...

Steven is a partner at Unorthodox Ventures, an early-stage investor, primarily focused on Medical Technology and Industrial Technology companies. Steven sits on the boards of Lumen (metabolic/nutritional device), Tushy (bidet), and Safkan (ear cleaning medical device).
 
Before joining Unorthodox Ventures, Steven worked for the prior 23 years as an investment banker, having held senior roles at Lehman Brothers, Stifel Financial, and Cowen & Co. Steven has executed over 100 transactions with aggregate deal value in excess of $30 billion.  

Steven headed the M&A efforts for the Financial Sponsors practice at Lehman Brothers, covered Financial Sponsors and headed...

Joy is co-founder and general partner of The 98, an early-stage venture firm that invests in women-led technology businesses. She is also a lecturer at Princeton University’s School of Engineering, where she teaches the university’s foundational class on entrepreneurship. Previously, Joy was executive vice president and general manager of Digital Video at Condé Nast Entertainment, a subsidiary of Condé Nast, overseeing twenty properties including Vogue, The New Yorker and Vanity Fair.
 
Joy is currently a board director and chairperson of the Compensation Committee at publicly listed Perion, an ad tech conglomerate, and chairperson of...